Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

NCT03799224 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Stem Cell Transplant Complications
Relapse Leukemia
Refractory Leukemia

Interventions

DRUG: Decitabine
DRUG: mBU/CY and ATG
DRUG: mBU/CY

Sponsor

Peking University People's Hospital